AUSTIN WILLIS: Open Payments
NPI 1023682986 · VALLEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 16 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 3 | $124 |
| Janssen Biotech, Inc. | 3 | $63 |
| ARGENX US, INC. | 3 | $56 |
| Integra LifeSciences Corporation | 1 | $43 |
| CSL Behring | 1 | $34 |
| Genentech USA, Inc. | 1 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Lundbeck LLC | 1 | $16 |
| MDD US Operations, LLC | 1 | $15 |
Products named: Nayzilam, CODMAN CERTAS, VYVGART HYTRULO, Hizentra, Ocrevus Zunovo, AUSTEDO XR, WAINUA, VYEPTI.
Industry payments across CA — which companies pay providers there.
